Zydus Lifesciences Limited (ZYDUSLIFE.BO)
INR 859.55
(2.64%)
INR 859.55
(2.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 43.1 Billion INR | 60.15% |
| 2023 | 26.91 Billion INR | 10.96% |
| 2022 | 24.25 Billion INR | -7.72% |
| 2021 | 26.28 Billion INR | 36.54% |
| 2020 | 19.25 Billion INR | -12.57% |
| 2019 | 22.02 Billion INR | -0.31% |
| 2018 | 22.08 Billion INR | 51.13% |
| 2017 | 14.61 Billion INR | -27.04% |
| 2016 | 20.03 Billion INR | 32.19% |
| 2015 | 15.15 Billion INR | 40.35% |
| 2014 | 10.79 Billion INR | 15.41% |
| 2013 | 9.35 Billion INR | 3.39% |
| 2012 | 9.04 Billion INR | -0.83% |
| 2011 | 9.12 Billion INR | 31.24% |
| 2010 | 6.95 Billion INR | 35.15% |
| 2009 | 5.14 Billion INR | 38.43% |
| 2008 | 3.71 Billion INR | 25.46% |
| 2007 | 2.96 Billion INR | 38.8% |
| 2006 | 2.13 Billion INR | 22.57% |
| 2005 | 1.74 Billion INR | -5.89% |
| 2004 | 1.85 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 15.81 Billion INR | 78.31% |
| 2024 Q2 | 8.79 Billion INR | -34.96% |
| 2024 FY | 49.04 Billion INR | 82.2% |
| 2024 Q3 | 8.87 Billion INR | 0.83% |
| 2024 Q1 | 13.52 Billion INR | 19.12% |
| 2023 Q2 | 6.33 Billion INR | -2.88% |
| 2023 FY | 26.91 Billion INR | 10.96% |
| 2023 Q4 | 11.35 Billion INR | 46.63% |
| 2023 Q3 | 7.74 Billion INR | 22.24% |
| 2023 Q1 | 6.52 Billion INR | 22.54% |
| 2022 Q1 | 7.5 Billion INR | 12.54% |
| 2022 FY | 24.25 Billion INR | -7.72% |
| 2022 Q4 | 5.32 Billion INR | -6.5% |
| 2022 Q3 | 5.69 Billion INR | -15.78% |
| 2022 Q2 | 6.76 Billion INR | -9.9% |
| 2021 Q2 | 6.66 Billion INR | 4.14% |
| 2021 FY | 26.28 Billion INR | 36.54% |
| 2021 Q1 | 6.4 Billion INR | 9.7% |
| 2021 Q4 | 6.66 Billion INR | 7.97% |
| 2021 Q3 | 6.17 Billion INR | -7.38% |
| 2020 Q2 | 4.9 Billion INR | -3.83% |
| 2020 Q1 | 5.09 Billion INR | -8.1% |
| 2020 FY | 19.25 Billion INR | -12.57% |
| 2020 Q4 | 5.83 Billion INR | 7.32% |
| 2020 Q3 | 5.43 Billion INR | 10.93% |
| 2019 Q2 | 5.7 Billion INR | -5.59% |
| 2019 Q4 | 5.54 Billion INR | -22.67% |
| 2019 Q1 | 6.04 Billion INR | -19.94% |
| 2019 Q3 | 7.17 Billion INR | 25.67% |
| 2019 FY | 22.02 Billion INR | -0.31% |
| 2018 Q1 | 1.76 Billion INR | -58.42% |
| 2018 Q3 | 7.37 Billion INR | -2.11% |
| 2018 Q4 | 7.55 Billion INR | 2.4% |
| 2018 FY | 22.08 Billion INR | 51.13% |
| 2018 Q2 | 7.53 Billion INR | 327.77% |
| 2017 Q1 | 4.54 Billion INR | -11.34% |
| 2017 FY | 14.61 Billion INR | -27.04% |
| 2017 Q4 | 4.23 Billion INR | 27.91% |
| 2017 Q3 | 3.31 Billion INR | -26.26% |
| 2017 Q2 | 4.49 Billion INR | -1.3% |
| 2016 Q2 | 5.58 Billion INR | 4.79% |
| 2016 FY | 20.03 Billion INR | 32.19% |
| 2016 Q3 | 5.5 Billion INR | -1.47% |
| 2016 Q1 | 5.32 Billion INR | 18.91% |
| 2016 Q4 | 5.13 Billion INR | -6.71% |
| 2015 Q2 | 3.62 Billion INR | 13.64% |
| 2015 Q3 | 4.02 Billion INR | 10.95% |
| 2015 Q4 | 4.47 Billion INR | 11.44% |
| 2015 Q1 | 3.18 Billion INR | -8.65% |
| 2015 FY | 15.15 Billion INR | 40.35% |
| 2014 Q3 | 2.58 Billion INR | 16.95% |
| 2014 FY | 10.79 Billion INR | 15.41% |
| 2014 Q4 | 3.49 Billion INR | 35.03% |
| 2014 Q2 | 2.21 Billion INR | -12.02% |
| 2014 Q1 | 2.51 Billion INR | 28.36% |
| 2013 Q1 | 3.23 Billion INR | 381.49% |
| 2013 Q2 | 1.93 Billion INR | -40.23% |
| 2013 Q3 | 2.13 Billion INR | 10.41% |
| 2013 FY | 9.35 Billion INR | 3.39% |
| 2013 Q4 | 1.95 Billion INR | -8.33% |
| 2012 Q2 | 6.29 Billion INR | 0.0% |
| 2012 Q3 | 2.33 Billion INR | -62.97% |
| 2012 Q4 | -1.14 Billion INR | -149.26% |
| 2012 FY | 9.04 Billion INR | -0.83% |
| 2011 FY | 9.12 Billion INR | 31.24% |
| 2010 FY | 6.95 Billion INR | 35.15% |
| 2009 FY | 5.14 Billion INR | 38.43% |
| 2008 FY | 3.71 Billion INR | 25.46% |
| 2007 FY | 2.96 Billion INR | 38.8% |
| 2006 FY | 2.13 Billion INR | 22.57% |
| 2005 FY | 1.74 Billion INR | -5.89% |
| 2004 FY | 1.85 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -648.632% |
| Aurobindo Pharma Limited | 42.2 Billion INR | -2.142% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -380.077% |
| Granules India Limited | 6.81 Billion INR | -532.373% |
| Indoco Remedies Limited | 1.29 Billion INR | -3235.038% |
| Achyut Healthcare Limited | 4.43 Million INR | -971215.908% |
| Ajanta Pharma Limited | 19.67 Billion INR | -119.07% |
| Alkem Laboratories Limited | 19.46 Billion INR | -121.494% |
| Alpa Laboratories Limited | 184.49 Million INR | -23264.608% |
| Brooks Laboratories Limited | 14.44 Million INR | -298424.931% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -2409.869% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -3401.784% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 36.354% |
| Eris Lifesciences Limited | 5.18 Billion INR | -731.905% |
| FDC Limited | 2.98 Billion INR | -1343.535% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -562.942% |
| Gufic Biosciences Limited | 1.32 Billion INR | -3141.347% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -875.15% |
| Ipca Laboratories Limited | 7.98 Billion INR | -440.147% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -8383.459% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 28467.894% |
| Lasa Supergenerics Limited | -458 Million INR | 9511.906% |
| Laurus Labs Limited | 3.94 Billion INR | -991.703% |
| Lupin Limited | 28.04 Billion INR | -53.709% |
| Mankind Pharma Limited | 21.51 Billion INR | -100.33% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -42878.066% |
| Megasoft Limited | -121.1 Million INR | 35695.026% |
| NATCO Pharma Limited | 25.96 Billion INR | -66.039% |
| Piramal Pharma Limited | 4.55 Billion INR | -845.972% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1780.513% |
| Sigachi Industries Limited | 1.47 Billion INR | -2824.698% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 58.672% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -835.554% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -17194.615% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -7466.402% |
| Windlas Biotech Limited | 1.29 Billion INR | -3218.757% |
| ZIM Laboratories Limited | 253.82 Million INR | -16882.693% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 1147.547% |
| Divi's Laboratories Limited | 33.08 Billion INR | -30.311% |
| Hester Biosciences Limited | 364.81 Million INR | -11716.288% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -1447.272% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -9321.389% |
| Bal Pharma Limited | 233.9 Million INR | -18328.962% |
| Strides Pharma Science Limited | 5.22 Billion INR | -724.886% |
| Venus Remedies Limited | 534.65 Million INR | -7962.643% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -1278.05% |
| Nectar Lifesciences Limited | 923.8 Million INR | -4566.239% |
| Shilpa Medicare Limited | 1.36 Billion INR | -3055.082% |
| Aarti Drugs Limited | 7.14 Billion INR | -503.003% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -2599.587% |
| Suven Life Sciences Limited | -1.22 Billion INR | 3616.579% |
| Ind-Swift Limited | 1.22 Billion INR | -3416.172% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | -201.81% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 1218.82% |
| Themis Medicare Limited | 392.58 Million INR | -10880.185% |
| Hikal Limited | 32.11 Million INR | -134147.898% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -70.147% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -6780.607% |
| Wockhardt Limited | -670 Million INR | 6533.881% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -730.738% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -475238.251% |
| Neuland Laboratories Limited | 5.31 Billion INR | -710.573% |
| Morepen Laboratories Limited | 4.17 Billion INR | -932.792% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -20619.539% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -156892.498% |